The results indicated a significant increase in p53 expression levels, 2.46-fold in HT29 cells, and 4.81-fold in SW260 cells at a concentration of 10 μM, demonstrating the potent inhibitory effect on tumor cell proliferation when utilizing hybrid 126 (Figure 45d). The gene discussed is TP53; the disease is neoplasm.